{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T23:23:30Z","timestamp":1750202610271},"reference-count":32,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.clinthera.2008.10.014","type":"journal-article","created":{"date-parts":[[2008,11,18]],"date-time":"2008-11-18T11:26:59Z","timestamp":1227007619000},"page":"1880-1885","source":"Crossref","is-referenced-by-count":7,"title":["In vitro stability of enoxaparin solutions (20 mg\/mL) diluted in 4% glucose"],"prefix":"10.1016","volume":"30","author":[{"given":"Rahul P.","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Narkowicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenn A.","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2008.10.014_bib1","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1182\/blood.V83.5.1251.1251","article-title":"Venous thromboembolic complications (VTE) in children: First analyses of the Canadian Registry of VTE","volume":"83","author":"Andrew","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.clinthera.2008.10.014_bib2","doi-asserted-by":"crossref","first-page":"F163","DOI":"10.1136\/fn.76.3.F163","article-title":"Neonatal symptomatic thromboembolism in Germany: Two year survey","volume":"76","author":"Nowak-G\u00f6ttl","year":"1997","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.clinthera.2008.10.014_bib3","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1542\/peds.96.5.939","article-title":"Neonatal thrombosis: Report of a prospective Canadian and international registry","volume":"96","author":"Schmidt","year":"1995","journal-title":"Pediatrics"},{"key":"10.1016\/j.clinthera.2008.10.014_bib4","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1160\/TH04-02-0131","article-title":"A case series of 72 neonates with renal vein thrombosis. Data from the 1-800-NO-CLOTS Registry","volume":"92","author":"Kuhle","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.clinthera.2008.10.014_bib5","doi-asserted-by":"crossref","first-page":"883","DOI":"10.2165\/00128072-200103120-00002","article-title":"Management of preterm infants with intracardiac thrombi: Use of thrombolytic agents","volume":"3","author":"Rimensberger","year":"2001","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.clinthera.2008.10.014_bib6","series-title":"Pediatric Thromboembolism and Stroke Protocols","year":"1997"},{"key":"10.1016\/j.clinthera.2008.10.014_bib7","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000090940","article-title":"Long-term treatment of thrombosis with enoxaparin in pediatric and adolescent patients","volume":"115","author":"Merkel","year":"2006","journal-title":"Acta Haematol"},{"key":"10.1016\/j.clinthera.2008.10.014_bib8","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00043426-200003000-00011","article-title":"Low-molecular-weight heparin in thrombotic disease in children and adolescents","volume":"22","author":"Punzalan","year":"2000","journal-title":"J Pediatr Hematol Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2008.10.014_bib9","first-page":"3445","article-title":"Antithrombotic therapy in children","volume":"119","author":"Monagle","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.clinthera.2008.10.014_bib10","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0022-3476(96)70273-1","article-title":"Low-molecular-weight heparin in pediatric patients with thrombotic disease: A dose finding study","volume":"128","author":"Massicotte","year":"1996","journal-title":"J Pediatr"},{"key":"10.1016\/j.clinthera.2008.10.014_bib11","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1345\/1542-6270(2000)034<1410:UOEIAP>2.0.CO;2","article-title":"Use of enoxaparin in a preterm infant","volume":"34","author":"Dunaway","year":"2000","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.clinthera.2008.10.014_bib12","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1001\/archneur.55.12.1533","article-title":"Anticoagulation therapy in pediatric patients with sinovenous thrombosis: A cohort study","volume":"55","author":"deVeber","year":"1998","journal-title":"Arch Neurol"},{"key":"10.1016\/j.clinthera.2008.10.014_bib13","series-title":"Lovenox\u00ae (enoxaparin sodium injection) [prescribing information]","year":"2007"},{"key":"10.1016\/j.clinthera.2008.10.014_bib14","series-title":"Clexane\u00ae and Clexane\u00ae Forte (enoxaparin sodium) injection [prescribing information]","year":"2007"},{"key":"10.1016\/j.clinthera.2008.10.014_bib15","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/ajhp\/60.7.709","article-title":"Expanding pharmacy technicians' role in medication teaching","volume":"60","author":"Chevalier","year":"2003","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.clinthera.2008.10.014_bib16","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0022-3476(00)90005-2","article-title":"The use of low molecular weight heparin in pediatric patients: A prospective cohort study","volume":"136","author":"Dix","year":"2000","journal-title":"J Pediatr"},{"key":"10.1016\/j.clinthera.2008.10.014_bib17","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1182\/blood.V70.1.165.165","article-title":"Development of the human coagulation system in the full-term infant","volume":"70","author":"Andrew","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.clinthera.2008.10.014_bib18","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0049-3848(89)90237-5","article-title":"The comparison of the pharmacokinetics of a low molecular weight heparin in the newborn and adult pig","volume":"56","author":"Andrew","year":"1989","journal-title":"Thromb Res"},{"key":"10.1016\/j.clinthera.2008.10.014_bib19","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00043426-199021000-00019","article-title":"Development of the hemostat system in the neonate and young in fant","volume":"12","author":"Andrew","year":"1990","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"10.1016\/j.clinthera.2008.10.014_bib20","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1056\/NEJM199603143341101","article-title":"A comparison of low-molecular-weight heparin administered pri marily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis","volume":"334","author":"Levine","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2008.10.014_bib21","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1345\/aph.1D107","article-title":"Anti-Xa stability of diluted enoxaparin for use in pediatrics","volume":"38","author":"Dager","year":"2004","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.clinthera.2008.10.014_bib22","doi-asserted-by":"crossref","first-page":"64S","DOI":"10.1378\/chest.119.1_suppl.64S","article-title":"Heparin and low-molecularweight heparin: Mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety","volume":"119","author":"Hirsh","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.clinthera.2008.10.014_bib23","series-title":"Modern Pharmaceutics","author":"Banker","year":"2002"},{"key":"10.1016\/j.clinthera.2008.10.014_bib24","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/ajhp\/53.2.167","article-title":"Compatibility and activity of enoxaparin sodium in 0.9% sodium chloride injection for 48 hours","volume":"53","author":"Mewborn","year":"1996","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.clinthera.2008.10.014_bib25","doi-asserted-by":"crossref","unstructured":"Patel RP, Narkowicz C, Jacobson GA. Investigation of freezing- and thawing-induced biological, chemical, and physical changes to enoxaparin solution [published online ahead of print July 25, 2008]. J Pharm Sci. doi:10.1002\/jps.21483.","DOI":"10.1002\/jps.21483"},{"key":"10.1016\/j.clinthera.2008.10.014_bib26","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/jps.2600760411","article-title":"Aggregation of commercial heparin samples in storage","volume":"76","author":"Racey","year":"1987","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.clinthera.2008.10.014_bib27","first-page":"7","article-title":"Dimethyl sulfoxide. Its steroid solubility and endocrinologic and pharmacologic-toxicologic characteristics","volume":"31","author":"Rosenkrantz","year":"1963","journal-title":"Cancer ChemotherRep"},{"key":"10.1016\/j.clinthera.2008.10.014_bib28","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1351\/pac199567111801","article-title":"The use of thermal analysis in the development of a better understanding of frozen food stability","volume":"67","author":"Goff","year":"1995","journal-title":"Pure Appl Chem"},{"key":"10.1016\/j.clinthera.2008.10.014_bib29","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.3168\/jds.S0022-0302(93)77456-1","article-title":"The influence of polysaccharides on the glass transition in frozen sucrose solutions and ice cream","volume":"76","author":"Goff","year":"1993","journal-title":"J Dairy Sci"},{"key":"10.1016\/j.clinthera.2008.10.014_bib30","series-title":"Assessment of stability and activity of enoxaparin sodium by capillary electrophoresis [Master's thesis]","author":"Patel","year":"2005"},{"key":"10.1016\/j.clinthera.2008.10.014_bib31","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1172\/JCI110791","article-title":"Persistent glucose production during glucose infusion in the neonate","volume":"71","author":"Cowett","year":"1983","journal-title":"J Clin Invest"},{"issue":"Suppl 2","key":"10.1016\/j.clinthera.2008.10.014_bib32","first-page":"24","article-title":"Low-molecular-weight heparins: An overview of their pharmacodynamics, pharmacokinetics and metabolism in humans","volume":"26","author":"Frydman","year":"1996","journal-title":"Haemostasis"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291808003354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291808003354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,21]],"date-time":"2023-05-21T04:01:48Z","timestamp":1684641708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291808003354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S0149291808003354"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2008.10.014","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}